{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:01:50Z","timestamp":1778860910729,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2017YFC1310000"],"award-info":[{"award-number":["2017YFC1310000"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prognosis of patients with advanced schistosomiasis is poor. Pre-existing prognosis studies did not differentiate the causes of the deaths. The objectives were to evaluate the 2-year overall survival (OS) and advanced schistosomiasis-specific survival (ASS) in patients with advanced schistosomiasis after discharge through competing risk analysis and to build predictive nomograms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data was extracted from a previously constructed database from Hubei province. Patients were enrolled from September 2014 to January 2015, with follow up to January 2017. OS and ASS were primary outcome measures. Nomograms for estimating 2-year OS and ASS rates after discharge were established based on univariate and multivariate Cox regression model and Fine and Gray\u2019s model. Their predictive performances were evaluated using C-index and validated in both internal and external validation cohorts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The training cohort included 1487 patients with advanced schistosomiasis. Two-year mortality rate of the training cohort was 8.27% (123\/1487). Competing events accounted for 26.83% (33\/123). Older age, splemomegaly clinical classification, abnormal serum DBil, AST, ALP and positive HBsAg were significantly associated with 2-year OS. Older age, splemomegaly clinical classification, abnormal serum AST, ALP and positive HBsAg were significantly associated with 2-year ASS. The established nomograms were well calibrated, and had good discriminative ability, with a C-index of 0.813 (95% CI 0.803\u20130.823) for 2-year OS prediction and 0.834 (95% CI 0.824\u20130.844) for 2-year ASS prediction. Their predictive performances were well validated in both internal and external validation cohorts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The effective predictors of 2-year OS and ASS were discovered through competing risk analysis. The nomograms could be used as convenient predictive tools in clinical practice to guide follow-up and aid accurate prognostic assessment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-020-02353-5","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T11:03:42Z","timestamp":1588763022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nomograms to predict 2-year overall survival and advanced schistosomiasis-specific survival after discharge: a competing risk analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Guo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengchao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"issue":"9948","key":"2353_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(14)61669-X","volume":"384","author":"F de Laval","year":"2014","unstructured":"de Laval F, et al. Human schistosomiasis: an emerging threat for Europe. Lancet. 2014;384(9948):1094\u20135.","journal-title":"Lancet"},{"issue":"10","key":"2353_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1473-3099(10)70099-2","volume":"10","author":"DJ Gray","year":"2010","unstructured":"Gray DJ, et al. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis. 2010;10(10):733\u20136.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2353_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40249-018-0391-x","volume":"7","author":"SH Xiao","year":"2018","unstructured":"Xiao SH, Sun J, Chen MG. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies. Infect Dis Poverty. 2018;7(1):9.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2353_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpara.2016.09.003","volume":"47","author":"Y Hu","year":"2017","unstructured":"Hu Y, et al. Assessment of the national schistosomiasis control program in a typical region along the Yangtze River China. Int J Parasitol. 2017;47(1):21\u20139.","journal-title":"Int J Parasitol"},{"issue":"5","key":"2353_CR5","first-page":"481","volume":"30","author":"Z Li-Juan","year":"2018","unstructured":"Li-Juan Z, et al. Endemic status of schistosomiasis in People\u2019s Republic of China in 2017. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2018;30(5):481\u20138.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"2","key":"2353_CR6","doi-asserted-by":"publisher","first-page":"e0006262","DOI":"10.1371\/journal.pntd.0006262","volume":"12","author":"G Li","year":"2018","unstructured":"Li G, et al. Comparison of three data mining models for prediction of advanced schistosomiasis prognosis in the Hubei province. PLoS Negl Trop Dis. 2018;12(2):e0006262.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2353_CR7","doi-asserted-by":"publisher","first-page":"e966","DOI":"10.1371\/journal.pntd.0000966","volume":"5","author":"TW Jia","year":"2011","unstructured":"Jia TW, et al. Quantifying quality of life and disability of patients with advanced schistosomiasis japonica. PLoS Negl Trop Dis. 2011;5(2):e966.","journal-title":"PLoS Negl Trop Dis"},{"key":"2353_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ebiom.2019.08.028","volume":"47","author":"G Li","year":"2019","unstructured":"Li G, et al. Derivation and external validation of a model to predict 2-year mortality risk of patients with advanced schistosomiasis after discharge. EBioMedicine. 2019;47:309\u201318.","journal-title":"EBioMedicine"},{"issue":"4","key":"2353_CR9","first-page":"471","volume":"24","author":"YX Nie","year":"2012","unstructured":"Nie YX, Xu TL. Cognitive behavioral therapy for depression in advanced schistosomiasis patients. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2012;24(4):471\u20133.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"5","key":"2353_CR10","first-page":"579","volume":"23","author":"N Yong-Xin","year":"2011","unstructured":"Yong-Xin N. Depression prevalence and quality of life of patients with advanced schistosomiasis. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011;23(5):579\u201381.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"6","key":"2353_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601\u20139.","journal-title":"Circulation"},{"issue":"3","key":"2353_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.7150\/jca.28991","volume":"10","author":"W Sun","year":"2019","unstructured":"Sun W, et al. Nomogram predicting cause-specific mortality in nonmetastatic male breast cancer: a competing risk analysis. J Cancer. 2019;10(3):583\u201393.","journal-title":"J Cancer"},{"issue":"12","key":"2353_CR13","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1007\/s00436-014-4143-y","volume":"113","author":"F Zhong","year":"2014","unstructured":"Zhong F, Liu C, Zhang X. Guideline adherence for the treatment of advanced Schistosomiasis japonica in Hubei China. Parasitol Res. 2014;113(12):4535\u201341.","journal-title":"Parasitol Res"},{"issue":"5","key":"2353_CR14","first-page":"451","volume":"27","author":"WC Deng","year":"2015","unstructured":"Deng WC, et al. Diagnosis and treatment of Schistosomiasis japonica-concensuses among ex- perts in Hunan, Hubei and Jiangxi provinces. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2015;27(5):451\u20136.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"2","key":"2353_CR15","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/j.cllc.2017.10.016","volume":"19","author":"H Zhou","year":"2018","unstructured":"Zhou H, et al. Nomogram to predict cause-specific mortality in patients with surgically resected stage I non-small-cell lung cancer: a competing risk analysis. Clin Lung Cancer. 2018;19(2):e195\u2013203.","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"2353_CR16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1200\/JCO.2012.42.4457","volume":"31","author":"L Yang","year":"2013","unstructured":"Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol. 2013;31(4):468\u201374.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2353_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/JCO.2009.22.4816","volume":"28","author":"A Kutikov","year":"2010","unstructured":"Kutikov A, et al. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol. 2010;28(2):311\u20137.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2353_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/jcm7120499","volume":"7","author":"M Provenzano","year":"2018","unstructured":"Provenzano M, et al. Competing-risk analysis of death and end stage kidney disease by hyperkalaemia status in non-dialysis chronic kidney disease patients receiving stable nephrology care. J Clin Med. 2018;7(12):499.","journal-title":"J Clin Med"},{"issue":"5","key":"2353_CR19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/jcm8050744","volume":"8","author":"SH Kim","year":"2019","unstructured":"Kim SH, et al. Perioperative factors for predicting the need for postoperative intensive care after major lung resection. J Clin Med. 2019;8(5):744.","journal-title":"J Clin Med"},{"issue":"9","key":"2353_CR20","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1161\/STROKEAHA.111.000304","volume":"44","author":"GJ de Man-van","year":"2013","unstructured":"de Man-van GJ, et al. In-hospital risk prediction for post-stroke depression: development and validation of the post-stroke depression prediction scale. Stroke. 2013;44(9):2441\u20135.","journal-title":"Stroke"},{"issue":"11","key":"2353_CR21","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1007\/s00436-016-5253-5","volume":"115","author":"LG Song","year":"2016","unstructured":"Song LG, et al. History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination. Parasitol Res. 2016;115(11):4071\u201381.","journal-title":"Parasitol Res"},{"issue":"9936","key":"2353_CR22","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, et al. Human schistosomiasis. Lancet. 2014;383(9936):2253\u201364.","journal-title":"Lancet"},{"key":"2353_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-0915-5_3","volume":"766","author":"FA Lewis","year":"2014","unstructured":"Lewis FA, Tucker MS. Schistosomiasis. Adv Exp Med Biol. 2014;766:47\u201375.","journal-title":"Adv Exp Med Biol"},{"issue":"18","key":"2353_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1001\/jama.2017.16326","volume":"318","author":"MT James","year":"2017","unstructured":"James MT, et al. Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury. JAMA. 2017;318(18):1787\u201397.","journal-title":"JAMA"},{"issue":"21","key":"2353_CR25","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.7150\/jca.20274","volume":"9","author":"W Shen","year":"2018","unstructured":"Shen W, Sakamoto N, Yang L. Cause-specific mortality prediction model for patients with basaloid squamous cell carcinomas of the head and neck: a competing risk analysis. J Cancer. 2018;9(21):4009\u201317.","journal-title":"J Cancer"},{"issue":"1","key":"2353_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12885-019-5398-6","volume":"19","author":"C He","year":"2019","unstructured":"He C, et al. Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery. BMC Cancer. 2019;19(1):178.","journal-title":"BMC Cancer"},{"issue":"4","key":"2353_CR27","first-page":"365","volume":"28","author":"L Jia-Xin","year":"2016","unstructured":"Jia-Xin L, et al. Investigation of direct medical expense for surgical patients with splenomegalic advanced schistosomiasis in Hunan Province from 2010 to 2014. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2016;28(4):365\u20139.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"5","key":"2353_CR28","first-page":"738","volume":"15","author":"LC Costa","year":"2016","unstructured":"Costa LC, et al. Schistosomal portal hypertension: randomized trial comparing endoscopic therapy alone or preceded by esophagogastric devascularization and splenectomy. Ann Hepatol. 2016;15(5):738\u201344.","journal-title":"Ann Hepatol"},{"issue":"11","key":"2353_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s12032-014-0282-3","volume":"31","author":"O Tanriverdi","year":"2014","unstructured":"Tanriverdi O. A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist\u2019s perspective. Med Oncol. 2014;31(11):282.","journal-title":"Med Oncol"},{"issue":"Suppl 1","key":"2353_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12072-017-9815-0","volume":"12","author":"S Piano","year":"2018","unstructured":"Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome. Hepatol Int. 2018;12(Suppl 1):122\u201334.","journal-title":"Hepatol Int"},{"issue":"6","key":"2353_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1753-4887.2010.00292.x","volume":"68","author":"JP Lalles","year":"2010","unstructured":"Lalles JP. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev. 2010;68(6):323\u201332.","journal-title":"Nutr Rev"},{"issue":"8","key":"2353_CR32","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s11605-011-1537-3","volume":"15","author":"MC Yu","year":"2011","unstructured":"Yu MC, et al. Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg. 2011;15(8):1440\u20139.","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"2353_CR33","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/cncr.10384","volume":"94","author":"TW Leung","year":"2002","unstructured":"Leung TW, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer. 2002;94(6):1760\u20139.","journal-title":"Cancer"},{"issue":"1","key":"2353_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.humpath.2010.05.020","volume":"42","author":"Y Li","year":"2011","unstructured":"Li Y, et al. Severe hepatosplenic schistosomiasis: clinicopathologic study of 102 cases undergoing splenectomy. Hum Pathol. 2011;42(1):111\u20139.","journal-title":"Hum Pathol"},{"issue":"8","key":"2353_CR35","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1016\/j.ijid.2013.01.023","volume":"17","author":"LH Huang","year":"2013","unstructured":"Huang LH, et al. The efficacy and safety of entecavir in patients with advanced schistosomiasis co-infected with hepatitis B virus. Int J Infect Dis. 2013;17(8):e606\u20139.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"2353_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1046\/j.1440-1746.2000.02172.x","volume":"15","author":"GJ Park","year":"2000","unstructured":"Park GJ, et al. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol. 2000;15(4):386\u201390.","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"2353_CR37","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3390\/ijms17122057","volume":"17","author":"M Du","year":"2016","unstructured":"Du M, et al. The Relationship between Serum bilirubin and elevated fibrotic indices among hbv carriers: a cross-sectional study of a chinese population. Int J Mol Sci. 2016;17(12):2057.","journal-title":"Int J Mol Sci"},{"issue":"9930","key":"2353_CR38","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749\u201361.","journal-title":"Lancet"},{"issue":"11","key":"2353_CR39","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/ndt\/gft355","volume":"28","author":"M Noordzij","year":"2013","unstructured":"Noordzij M, et al. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant. 2013;28(11):2670\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2353_CR40","doi-asserted-by":"publisher","first-page":"e0007174","DOI":"10.1371\/journal.pntd.0007174","volume":"13","author":"L Song","year":"2019","unstructured":"Song L, et al. Reversal of liver fibrosis after splenectomy in a patient with advanced Schistosomiasis japonica: a case report with 4-year follow-up. PLoS Negl Trop Dis. 2019;13(4):e0007174.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2353_CR41","doi-asserted-by":"publisher","first-page":"e1960","DOI":"10.1371\/journal.pntd.0001960","volume":"7","author":"DB Lu","year":"2013","unstructured":"Lu DB, Zhou L, Li Y. Improving access to anti-schistosome treatment and care in nonendemic areas of China: lessons from one case of advanced Schistosomiasis japonica. PLoS Negl Trop Dis. 2013;7(1):e1960.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"2353_CR42","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1007\/s00436-016-5207-y","volume":"115","author":"L Song","year":"2016","unstructured":"Song L, et al. Assessment of the effect of treatment and assistance program on advanced patients with schistosomiasis japonica in China from 2009 to 2014. Parasitol Res. 2016;115(11):4267\u201373.","journal-title":"Parasitol Res"},{"issue":"1","key":"2353_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/liv.12891","volume":"36","author":"E Sinkala","year":"2016","unstructured":"Sinkala E, et al. Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis. Liver Int. 2016;36(1):145\u201350.","journal-title":"Liver Int"},{"issue":"4","key":"2353_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1590\/S0004-28032005000400006","volume":"42","author":"RM Wyszomirska","year":"2005","unstructured":"Wyszomirska RM, et al. High serum laminin and type IV collagen levels in schistosomiasis mansoni. Arq Gastroenterol. 2005;42(4):221\u20135.","journal-title":"Arq Gastroenterol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02353-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02353-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02353-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:15:33Z","timestamp":1620260133000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02353-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2353"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02353-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments. The study was approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology. All patients were anonymous and a waiver of informed consent was granted.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}